Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Biometrics ; 72(3): 936-44, 2016 09.
Article in English | MEDLINE | ID: mdl-26821783

ABSTRACT

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative condition characterized by the progressive deterioration of motor neurons in the cortex and spinal cord. Using an automated robotic microscope platform that enables the longitudinal tracking of thousands of single neurons, we examine the effects a large library of compounds on modulating the survival of primary neurons expressing a mutation known to cause ALS. The goal of our analysis is to identify the few potentially beneficial compounds among the many assayed, the vast majority of which do not extend neuronal survival. This resembles the large-scale simultaneous inference scenario familiar from microarray analysis, but transferred to the survival analysis setting due to the novel experimental setup. We apply a three-component mixture model to censored survival times of thousands of individual neurons subjected to hundreds of different compounds. The shrinkage induced by our model significantly improves performance in simulations relative to performing treatment-wise survival analysis and subsequent multiple testing adjustment. Our analysis identified compounds that provide insight into potential novel therapeutic strategies for ALS.


Subject(s)
High-Throughput Screening Assays/methods , Models, Statistical , Survival Analysis , Amyotrophic Lateral Sclerosis/drug therapy , Amyotrophic Lateral Sclerosis/mortality , Computer Simulation , Humans , Motor Neurons/drug effects
2.
Anesth Analg ; 116(3): 589-95, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23400992

ABSTRACT

BACKGROUND: Although general anesthetics are recognized for their potential to render patients unconscious during surgery, exposure can also lead to long-term outcomes of both cellular damage and protection. As regards the latter, delayed anesthetic preconditioning is an evolutionarily conserved physiological response that has the potential for protecting against ischemic injury in a number of tissues. Although it is known that delayed preconditioning requires de novo protein synthesis, knowledge of anesthetic-regulated genes is incomplete. In this study, we used the conserved nature of preconditioning to analyze differentially regulated genes in 3 different rat tissues. We hypothesized that by selecting those genes regulated in multiple tissues, we could develop a focused list of gene candidates potentially involved in delayed anesthetic preconditioning. METHODS: Young adult male Sprague-Dawley rats were anesthetized with a 2% isoflurane/98% air mixture for 90 minutes. Immediately after anesthetic exposure, animals were euthanized and liver, kidney, and heart were removed and total RNA was isolated. Differential gene expression was determined using rat oligonucleotide gene arrays. Array data were analyzed to select for genes that were significantly regulated in multiple tissues. RESULTS: All 3 tissues showed differentially regulated genes in response to a clinically relevant exposure to isoflurane. Analysis of coordinately regulated genes yielded a focused list of 34 potential gene candidates with a range of ontologies including regulation of inflammation, modulation of apoptosis, regulation of ion gradients, and maintenance of energy pathways. CONCLUSIONS: Through using an analysis approach focusing on coordinately regulated genes, we were able to generate a focused list of interesting gene candidates with potential to enable future preconditioning studies.


Subject(s)
Anesthesia, Inhalation , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Ischemic Preconditioning/methods , Isoflurane/administration & dosage , Oligonucleotide Array Sequence Analysis/methods , Animals , Gene Expression Profiling/methods , Heart/drug effects , Heart/physiology , Kidney/drug effects , Kidney/physiology , Liver/drug effects , Liver/physiology , Male , Microarray Analysis/methods , Rats , Rats, Sprague-Dawley
3.
PLoS One ; 9(12): e91608, 2014.
Article in English | MEDLINE | ID: mdl-25526593

ABSTRACT

Treatment options for people living with amyotrophic lateral sclerosis (ALS) are limited and ineffective. Recently, dexpramipexole (RPPX) was advanced into human ALS clinical trials. In the current studies, we investigated RPPX in two parallel screening systems: 1) appropriately powered, sibling-matched, gender-balanced survival efficacy screening in high-copy B6-SJL-SOD1G93A/Gur1 mice, and 2) high-content neuronal survival screening in primary rat cortical neurons transfected with wild-type human TDP43 or mutant human TDP43. In both cases, we exposed the test systems to RPPX levels approximating those achieved in human Phase II clinical investigations. In SOD1G93A mice, no effect was observed on neuromotor disease progression or survival. In primary cortical neurons transfected with either mutant or wild-type human TDP43, a marginally significant improvement in a single indicator of neuronal survival was observed, and only at the 10 µM RPPX treatment. These systems reflect both mutant SOD1- and TDP43-mediated forms of neurodegeneration. The systems also reflect both complex non-cell autonomous and neuronal cell autonomous disease mechanisms. The results of these experiments, taken in context with results produced by other molecules tested in both screening systems, do not argue positively for further study of RPPX in ALS.


Subject(s)
Amyotrophic Lateral Sclerosis/drug therapy , Antioxidants/therapeutic use , Benzothiazoles/therapeutic use , Neurons/drug effects , Neuroprotective Agents/therapeutic use , Amyotrophic Lateral Sclerosis/genetics , Animals , Antioxidants/pharmacology , Benzothiazoles/pharmacology , Cells, Cultured , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Humans , Mice , Mice, Inbred C57BL , Neurons/metabolism , Neuroprotective Agents/pharmacology , Pramipexole , Rats , Rats, Long-Evans , Superoxide Dismutase/genetics , Superoxide Dismutase-1
4.
Nat Genet ; 46(2): 152-60, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24336168

ABSTRACT

Amyotrophic lateral sclerosis (ALS) is a fatal, late-onset neurodegenerative disease primarily affecting motor neurons. A unifying feature of many proteins associated with ALS, including TDP-43 and ataxin-2, is that they localize to stress granules. Unexpectedly, we found that genes that modulate stress granules are strong modifiers of TDP-43 toxicity in Saccharomyces cerevisiae and Drosophila melanogaster. eIF2α phosphorylation is upregulated by TDP-43 toxicity in flies, and TDP-43 interacts with a central stress granule component, polyA-binding protein (PABP). In human ALS spinal cord neurons, PABP accumulates abnormally, suggesting that prolonged stress granule dysfunction may contribute to pathogenesis. We investigated the efficacy of a small molecule inhibitor of eIF2α phosphorylation in ALS models. Treatment with this inhibitor mitigated TDP-43 toxicity in flies and mammalian neurons. These findings indicate that the dysfunction induced by prolonged stress granule formation might contribute directly to ALS and that compounds that mitigate this process may represent a novel therapeutic approach.


Subject(s)
Adenine/analogs & derivatives , Amyotrophic Lateral Sclerosis/genetics , DNA-Binding Proteins/metabolism , Eukaryotic Initiation Factor-2/metabolism , Indoles/pharmacology , Adenine/pharmacology , Analysis of Variance , Animals , Ataxins , DNA-Binding Proteins/genetics , Drosophila melanogaster , Gene Ontology , High-Throughput Screening Assays , Humans , Immunoblotting , Immunohistochemistry , Luminescent Proteins , Motor Neurons/metabolism , Nerve Tissue Proteins/metabolism , Phosphorylation/drug effects , Poly(A)-Binding Proteins/metabolism , RNA Interference , Retina/metabolism , Retina/ultrastructure , Saccharomyces cerevisiae , Saccharomyces cerevisiae Proteins/metabolism , Small Molecule Libraries , Spinal Cord/cytology , Spinal Cord/metabolism , Red Fluorescent Protein
5.
ACS Chem Biol ; 8(9): 1931-8, 2013 Sep 20.
Article in English | MEDLINE | ID: mdl-23841803

ABSTRACT

Engineered analog-sensitive (AS) protein kinases have emerged as powerful tools for dissecting phospho-signaling pathways, for elucidating the cellular function of individual kinases, and for deciphering unanticipated effects of clinical therapeutics. A crucial and necessary feature of this technology is a bioorthogonal small molecule that is innocuous toward native cellular systems but potently inhibits the engineered kinase. In order to generalize this method, we sought a molecule capable of targeting divergent AS-kinases. Here we employ X-ray crystallography and medicinal chemistry to unravel the mechanism of current inhibitors and use these insights to design the most potent, selective, and general AS-kinase inhibitors reported to date. We use large-scale kinase inhibitor profiling to characterize the selectivity of these molecules as well as examine the consequences of potential off-target effects in chemical genetic experiments. The molecules reported here will serve as powerful tools in efforts to extend AS-kinase technology to the entire kinome and the principles discovered may help in the design of other engineered enzyme/ligand pairs.


Subject(s)
Drug Design , Protein Kinase Inhibitors/chemistry , Protein Kinase Inhibitors/pharmacology , Crystallography, X-Ray , Humans , Models, Molecular , Protein Kinases/chemistry , Protein Kinases/metabolism
6.
Neuron ; 71(5): 858-68, 2011 Sep 08.
Article in English | MEDLINE | ID: mdl-21903079

ABSTRACT

In Parkinson's disease (PD), dopamine depletion alters neuronal activity in the direct and indirect pathways and leads to increased synchrony in the basal ganglia network. However, the origins of these changes remain elusive. Because GABAergic interneurons regulate activity of projection neurons and promote neuronal synchrony, we recorded from pairs of striatal fast-spiking (FS) interneurons and direct- or indirect-pathway MSNs after dopamine depletion with 6-OHDA. Synaptic properties of FS-MSN connections remained similar, yet within 3 days of dopamine depletion, individual FS cells doubled their connectivity to indirect-pathway MSNs, whereas connections to direct-pathway MSNs remained unchanged. A model of the striatal microcircuit revealed that such increases in FS innervation were effective at enhancing synchrony within targeted cell populations. These data suggest that after dopamine depletion, rapid target-specific microcircuit organization in the striatum may lead to increased synchrony of indirect-pathway MSNs that contributes to pathological network oscillations and motor symptoms of PD.


Subject(s)
Action Potentials/physiology , Corpus Striatum/cytology , Dopamine/deficiency , Interneurons/physiology , Nerve Net/physiology , Neural Inhibition/physiology , Action Potentials/drug effects , Animals , Axons/metabolism , Axons/ultrastructure , Benzazepines/pharmacology , Biophysics , Computer Simulation , Corpus Striatum/drug effects , Desipramine/pharmacology , Dopamine Antagonists/pharmacology , Electric Stimulation , Enzyme Inhibitors/pharmacology , Excitatory Postsynaptic Potentials/drug effects , In Vitro Techniques , Interneurons/cytology , Interneurons/drug effects , Interneurons/metabolism , Lysine/analogs & derivatives , Lysine/metabolism , Mice , Models, Neurological , Nerve Net/drug effects , Neural Inhibition/drug effects , Oxidopamine/pharmacology , Parvalbumins/metabolism , Sulpiride/pharmacology , Sympatholytics/pharmacology , Time Factors , Tyrosine 3-Monooxygenase/metabolism , Vesicular Inhibitory Amino Acid Transport Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL